ClaimsPeople

Balaji Srinivasan

Balaji S. Srinivasan is a technology entrepreneur, investor and author who was formerly CTO of Coinbase and a general partner at Andreessen Horowitz, and who founded Network School.

1,569 claims collected, 251 researched, 80 resolved. Report of 4 November 2026, method 0.1.0+c876030c.

Scores by kind of claim

Each kind of claim is scored on its own, out of 100: the share that held up, with the range it likely falls in. Fewer resolved claims give a wider range.

  • Factual claims

    Statements about the present or the past, checked against the record: did they hold up?

    72 65 79

    High confidence, 60 factual claims resolved. From 15 documents, 2018 to 2025; 19 documents sampled from 34 candidates found.

    Not scored: 35 unresolvable, 2 checkable only against their own records.

  • Predictions

    Statements about events outside the person's control, checked once they fell due: did they come true?

    66 54 78

    Medium confidence, 19 predictions resolved. From 5 documents, 2018 to 2024; 19 documents sampled from 34 candidates found.

    Not scored: 111 unresolvable. 21 more fall due later.

    Does not yet allow for how likely each prediction was when made.

  • Promises

    Commitments to the person's or organisation's own future action, with something to deliver: was it delivered?

    Insufficient record: 1 promise resolved, 5 needed for a score.

    Not scored: 2 unresolvable.

All types combined: 71 (likely 64 to 77, high confidence), from 79 claims: 60 factual claims, 19 predictions. It mixes kinds of claim in different proportions for different people, so compare people kind by kind.

Balaji Srinivasan's claims

9 claims

9 claims, sorted by newest said. Choose a claim to read it in full.
VerdictKindSaidClaimTopic
Mixed Factual 3 Aug 2025 AI is currently having a decentralizing rather than centralizing effect on the industry. Factual · 3 Aug 2025 AI, the economy and work
Mixed Factual 28 Jul 2025 The keys are the keys to the car itself: a digital signature starts the engine. Factual · 28 Jul 2025 Technology
Mixed Factual 3 Aug 2024 Friedrich Hayek predicted Bitcoin. Factual · 3 Aug 2024 Economics and markets
Mixed Factual 25 Mar 2021 The big media companies are basically nepotistic endeavors, passed down from father to son. Factual · 25 Mar 2021 Economics and markets
Mixed Prediction 25 Mar 2021 He said he feared that, if vaccines were rolled out and enough Americans took them, by 2023 or 2024 people would be spoiling for a fight with China as the one legitimated enemy. Prediction · 25 Mar 2021 Other global risks
Mixed Prediction 30 Mar 2020 When US stimulus checks arrive, people will spend them on consumer staples, after which prices will rise. Prediction · 30 Mar 2020 Economics and markets
Mixed Factual 29 Mar 2020 Vox did not accurately relay what experts were saying at the time; WHO had declared a global emergency in late January 2020, weeks before the Recode handshake piece. Factual · 29 Mar 2020 Other
Mixed Prediction 13 Mar 2020 Testing may need to become extremely routine, effectively mainstreaming genomics. Prediction · 13 Mar 2020 Biosecurity
Mixed Prediction 13 Mar 2020 Srinivasan said he thought China would build a nationwide system that constantly sequences and tests its population, then quarantines and vaccinates areas where a virus is rising. Prediction · 13 Mar 2020 Biosecurity
Back to the list

Prediction Biosecurity

“And it may turn out that we need to make testing extremely routine, which would basically mainstream genomics.”

Balaji Srinivasan, podcast guest 13 March 2020 #78 Balaji Srinivasan: Exploring COVID-19 — The Knowledge Project (HappyScribe)

Testing may need to become extremely routine, effectively mainstreaming genomics.

Mixed Partly true and partly false in roughly equal measure.

The second judge would not resolve this claim; the verdict shown is the first judge's.

What would count as true or false

Judged at end-2021. The claim has two linked parts: (a) COVID testing became extremely routine, meaning frequent repeat testing built into ordinary life for large parts of the population (for example mass free home antigen tests, routine workplace or school screening, testing required for travel or venues); and (b) this mainstreamed genomics, meaning genomic or nucleic-acid sequencing and analysis became a widespread, everyday technology (for example large-scale routine viral genome sequencing for variant surveillance in many countries, and broad public familiarity with or consumer use of molecular or genomic testing). TRUE: both (a) and (b) are documented. MOSTLY TRUE: (a) clearly holds and genomic sequencing grew greatly and became routine in public health, but not quite in everyday consumer use. MIXED: (a) holds but there is no meaningful mainstreaming of genomics beyond specialist labs (or the reverse). MOSTLY FALSE: testing grew but stayed occasional or symptom-driven for most people, with no mainstreaming of genomics. FALSE: testing never became routine for most people and genomics did not spread beyond specialist use. The claim's hedge ('may') does not lower the bar for the outcome itself.

Evidence

  1. Twice weekly rapid testing to be available to everyone in England UK Government (GOV.UK, Department of Health and Social Care) · 5 April 2021
    “Everyone in England, including those without symptoms, will be able to take a free rapid coronavirus (COVID-19) test twice a week”
  2. COVID-19: general public testing behaviours UK Health Security Agency (GOV.UK) · 19 October 2023
    “At the end of March 2022 (the period just before the end of UTO), the percentage of people who had taken an LFD test in the last 2 weeks dropped to 40% (6) from the peak of 59% in January 2022.”
  3. COVID-19: general public testing behaviours UK Health Security Agency (GOV.UK) · 19 October 2023
    “The UTO paved the way for widespread community based self-testing for COVID-19, allowing all individuals the means to rapidly assess their likelihood of being infectious without needing to use a laboratory process.”
  4. [PDF] Nathan D. Grubaugh, PhD - Congress.gov US Congress, House Committee on Science, Space, and Technology (written testimony of Yale School of Public Health epidemiologist Nathan D. Grubaugh) · 12 May 2021
    “The United States has so far sequenced 0.5-1% of the total COVID-19 cases, though sequencing has significantly increased in recent months.”

Reasoning

E1 shows that from April 2021 everyone in England, including people without symptoms, could take a free rapid test twice a week. E3 describes this as widespread community self-testing. Together they support part (a), routine frequent testing, at least in England. E2's figure of 59% testing within two weeks is from January 2022, just after the end-2021 judging date. For part (b), the only evidence is E4: in May 2021 the US had sequenced 0.5–1% of COVID-19 cases, though sequencing was growing. The rapid tests in E1 and E3 are not genomic tests, and nothing here shows genomics becoming an everyday technology outside specialist labs. That matches the 'mixed' outcome in the criteria.

Cite this claim

Balaji Srinivasan, “Testing may need to become extremely routine, effectively mainstreaming genomics.” (said 13 March 2020). Verdict: mixed. Reliability API, claim c_109a8b464572, method 0.1.0+c876030c. https://epistacklabs.com/claims/c_109a8b464572

Claims without a verdict

Is a verdict here wrong, or do you speak for Balaji Srinivasan? Reply on the claim's own page, with the form at its foot (how replies work). Verdicts are made automatically; how verdicts and scores are made.